Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. L. Paggiaro (Pisa, Italy). Potential usefulness of phenotyping in asthma and COPD. ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases

Member's Comments

No comment yet.

Related content which might interest you: Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Role of functional assessment in asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Optimization of diagnostics and differential diagnostics of bronchial asthma and COPD Source: Eur Respir J 2007; 30: Suppl. 51, 618s Year: 2007 The need for asthma phenotyping Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018 The need for asthma phenotyping Source: International Congress 2017 – PG15 Asthma stratification Year: 2017 Targeting traits in asthma and COPD Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target! Year: 2021 Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD Source: Eur Respir J 2013; 42: 891-892 Year: 2013 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Evaluation of markers for exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005 Identifying asthma features in severe COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Targeting the epigenome in asthma and COPD Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 Pulmonary biomarkers in asthma and COPD Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 LSC Abstract – Potential use of β-blockers to reduce COPD exacerbations Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Mechanisms in COPD compared with asthma Source: Breathe 2008; 5: 134-144 Year: 2008 Ykl-40 and phenotyping of severe asthma Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities Source: Eur Respir J 2014; 43: 662-664 Year: 2014 Methodologies for study of COPD exacerbations Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview Year: 2012